相似文献
1
Tackling neurodegenerative diseases with genomic engineering: A new stem cell initiative from the NIH.
Neuron. 2021 Apr 7;109(7):1080-1083. doi: 10.1016/j.neuron.2021.03.022.
2
Methods of Generation of Induced Pluripotent Stem Cells and Their Application for the Therapy of Central Nervous System Diseases.
Bull Exp Biol Med. 2020 Feb;168(4):566-573. doi: 10.1007/s10517-020-04754-4. Epub 2020 Mar 10.
3
Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Brain Res. 2016 May 1;1638(Pt A):30-41. doi: 10.1016/j.brainres.2015.09.023. Epub 2015 Sep 28.
4
Neural stem cell-based treatment for neurodegenerative diseases.
Neuropathology. 2013 Oct;33(5):491-504. doi: 10.1111/neup.12020. Epub 2013 Feb 5.
5
Developing neural stem cell-based treatments for neurodegenerative diseases.
Stem Cell Res Ther. 2014 May 30;5(3):72. doi: 10.1186/scrt461.
6
Human embryonic stem cell therapies for neurodegenerative diseases.
CNS Neurol Disord Drug Targets. 2011 Jun;10(4):440-8. doi: 10.2174/187152711795564001.
7
Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery.
Neurol Sci. 2015 Jan;36(1):21-7. doi: 10.1007/s10072-014-1989-9. Epub 2014 Oct 30.
8
Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.
Cell Transplant. 2014;23(4-5):435-9. doi: 10.3727/096368914X678274. Epub 2014 Mar 11.
9
Harnessing diversity to study Alzheimer's disease: A new iPSC resource from the NIH CARD and ADNI.
Neuron. 2024 Mar 6;112(5):694-697. doi: 10.1016/j.neuron.2024.01.026. Epub 2024 Feb 21.
10
Stem Cell Technology for (Epi)genetic Brain Disorders.
Adv Exp Med Biol. 2017;978:443-475. doi: 10.1007/978-3-319-53889-1_23.
引用本文的文献
1
CHI3L1/YKL-40 signaling inhibits neurogenesis in models of Alzheimer's disease.
Sci Adv. 2025 Jul 18;11(29):eadv1492. doi: 10.1126/sciadv.adv1492.
2
Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonism.
bioRxiv. 2025 Jun 25:2025.06.23.661126. doi: 10.1101/2025.06.23.661126.
3
Large-scale HLA immunopeptidome and interactome profiling in microglia.
bioRxiv. 2025 Apr 26:2025.04.23.650327. doi: 10.1101/2025.04.23.650327.
4
Non-coding variation in dementias: mechanisms, insights, and challenges.
NPJ Dement. 2025;1(1):9. doi: 10.1038/s44400-025-00012-4. Epub 2025 Jun 3.
5
Somatic and Stem Cell Bank to study the contribution of African ancestry to dementia: African iPSC Initiative.
Alzheimers Dement. 2025 Apr;21(4):e70145. doi: 10.1002/alz.70145.
6
Somatic and Stem Cell Bank to Study the Contribution of African Ancestry to Dementia: African iPSC Initiative.
medRxiv. 2025 Jan 27:2025.01.24.25320911. doi: 10.1101/2025.01.24.25320911.
7
Amyloid-β can activate JNK signalling via WNT5A-ROR2 to reduce synapse formation in Alzheimer's disease.
J Cell Sci. 2025 Feb 1;138(3). doi: 10.1242/jcs.263526. Epub 2025 Feb 5.
8
Protocol for live imaging of axonal transport in iPSC-derived iNeurons.
STAR Protoc. 2025 Mar 21;6(1):103556. doi: 10.1016/j.xpro.2024.103556. Epub 2025 Jan 12.
9
Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease.
Alzheimers Res Ther. 2025 Jan 4;17(1):5. doi: 10.1186/s13195-024-01659-6.
10
Endo-IP and lyso-IP toolkit for endolysosomal profiling of human-induced neurons.
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2419079121. doi: 10.1073/pnas.2419079121. Epub 2024 Dec 5.
本文引用的文献
1
Models of Neurodegenerative Diseases.
Front Cell Dev Biol. 2020 May 13;8:328. doi: 10.3389/fcell.2020.00328. eCollection 2020.
2
A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies.
Stem Cell Reports. 2019 Nov 12;13(5):939-955. doi: 10.1016/j.stemcr.2019.09.006. Epub 2019 Oct 17.
3
PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia.
Stem Cell Reports. 2019 Oct 8;13(4):669-683. doi: 10.1016/j.stemcr.2019.08.004. Epub 2019 Sep 12.
4
A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Neuron. 2019 Oct 23;104(2):256-270.e5. doi: 10.1016/j.neuron.2019.07.010. Epub 2019 Aug 12.
5
Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.
Stem Cell Reports. 2017 Oct 10;9(4):1221-1233. doi: 10.1016/j.stemcr.2017.08.019. Epub 2017 Sep 28.
6
iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases.
Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042.
7
The human-induced pluripotent stem cell initiative-data resources for cellular genetics.
Nucleic Acids Res. 2017 Jan 4;45(D1):D691-D697. doi: 10.1093/nar/gkw928. Epub 2016 Oct 12.
8
CRISPR/Cas9 for Human Genome Engineering and Disease Research.
Annu Rev Genomics Hum Genet. 2016 Aug 31;17:131-54. doi: 10.1146/annurev-genom-083115-022258. Epub 2016 May 23.
9
The Parkinson Progression Marker Initiative (PPMI).
Prog Neurobiol. 2011 Dec;95(4):629-35. doi: 10.1016/j.pneurobio.2011.09.005. Epub 2011 Sep 14.
Zotero 插件